NNMT dysregulation is implicated across obesity, insulin resistance, liver pathology, and other disorders
Rather than morning administration competing with the growth hormone peak stimulated by secretagogues (often administered at night), AOD-9604 moves to morning while CJC-1295/Ipamorelin administers before bed
How 5-Amino-1MQ May Affect NNMT and Metabolism 5-Amino-1MQ is commonly discussed because it may inhibit nicotinamide N-methyltransferase, also known as NNMT
They aim to boost B12s benefits by adding extra nutrients
Its mixed with saline solution (0.9% sodium chloride) or dextrose solution (5% dextrose) before being given
References ACS Chemical Biology (2023) Synthetic ERR// Agonist Induces an ERR-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity Journal of Pharmacology and Experimental Therapeutics (2024) A Synthetic ERR Agonist Alleviates Metabolic Syndrome Circulation (2024) Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function American Journal of Pathology (2023) Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney
